Response to the changing epidemiology of meningococcal disease in North America 1945-2010

Julie A. Bettinger; David W. Scheifele; Scott A. Halperin; Wendy Vaudry; Nicole Le Saux

doi:10.4161/hv.24009

Response to the changing epidemiology of meningococcal disease in North America 1945-2010

Julie A. Bettinger, David W. Scheifele, Scott A. Halperin, Wendy Vaudry, Nicole Le Saux

Economics, Econometrics and Finance

科研成果: 期刊稿件 › 快报 › 同行评审

3 引用（Scopus）

源语言	英语
页（从-至）	1323-1324
页数	2
期刊	Human Vaccines and Immunotherapeutics
卷	9
期	6
DOI	https://doi.org/10.4161/hv.24009
出版状态	已出版 - 6月 2013

!!!ASJC Scopus Subject Areas

免疫学和过敏症
药理学
免疫学

访问文件

10.4161/hv.24009

其它文件与链接

引用此

@article{ce827039132c45138aac6c66d89ca069,

title = "Response to the changing epidemiology of meningococcal disease in North America 1945-2010",

keywords = "Epidemiology, Literature review, Meningococcal disease, Neisseria meningitidis, North America",

author = "Bettinger, {Julie A.} and Scheifele, {David W.} and Halperin, {Scott A.} and Wendy Vaudry and Saux, {Nicole Le}",

year = "2013",

month = jun,

doi = "10.4161/hv.24009",

language = "English",

volume = "9",

pages = "1323--1324",

journal = "Human Vaccines and Immunotherapeutics",

issn = "2164-5515",

publisher = "Landes Bioscience",

number = "6",

}

TY - JOUR

T1 - Response to the changing epidemiology of meningococcal disease in North America 1945-2010

AU - Bettinger, Julie A.

AU - Scheifele, David W.

AU - Halperin, Scott A.

AU - Vaudry, Wendy

AU - Saux, Nicole Le

PY - 2013/6

Y1 - 2013/6

KW - Epidemiology

KW - Literature review

KW - Meningococcal disease

KW - Neisseria meningitidis

KW - North America

UR - http://www.scopus.com/inward/record.url?scp=84880658925&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880658925&partnerID=8YFLogxK

U2 - 10.4161/hv.24009

DO - 10.4161/hv.24009

M3 - Letter

C2 - 23454840

AN - SCOPUS:84880658925

SN - 2164-5515

VL - 9

SP - 1323

EP - 1324

JO - Human Vaccines and Immunotherapeutics

JF - Human Vaccines and Immunotherapeutics

IS - 6

ER -